Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206490 · ClinicalTrials.gov registry record · Phase 2
Trial of Naltrexone and Dextromethorphan for Gulf War Illness
A Phase 2 study, sponsored by East Carolina University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02206490 is a Phase 2 study that has completed, run by East Carolina University. The registered enrollment target is 60 participants.
The verdict
NCT02206490, a Phase 2 study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments with FDA approved generic drugs are being administered to see if they help with the symptoms of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and thinking; widespread chronic pain; and autonimic dysfunction. Drugs to be tested are dextromethorphan and naltrexone.
Interventions
- DRUG Dextromethorphan
- DRUG naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02206490
The ClinicalTrials.gov registry entry for NCT02206490 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Carolina University, which has 58 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dextromethorphan is the first listed.
NCT02206490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02206490 about?
NCT02206490 is a clinical study titled "Trial of Naltrexone and Dextromethorphan for Gulf War Illness". Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments with FDA approved generic drugs are being administered to see if they help with the symptoms of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and thinking; widespread chroni...
What is the current status of trial NCT02206490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02206490?
The interventions under investigation include: Dextromethorphan (DRUG), naltrexone (DRUG).
Who is sponsoring clinical trial NCT02206490?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.